Filter registries Oper. in, Oper. out
Check pre-conditions None
Include endpoints None
Check conditions
Apply sex-specific rule None
DM_EYE_OPER_INJECT_GEL_VITR
Extra metadata
List of similar endpoints to
Injection of e.g. viscoelastic gel into the vitreous cavity
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 131 | 54 | 77 |
| Unadjusted prevalence (%) | 0.05 | 0.04 | 0.07 |
| Mean age at first event (years) | 47.83 | 45.23 | 49.66 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | - | - | - | - |
| 15 years | - | - | - | - |
| 5 years | - | - | - | - |
| 1 year | - | - | - | - |
Index endpoint: DM_EYE_OPER_INJECT_GEL_VITR – Injection of e.g. viscoelastic gel into the vitreous cavity
GWS hits:
before Injection of e.g. viscoelastic gel into the vitreous cavity
after Injection of e.g. viscoelastic gel into the vitreous cavity
Loading survival analyses plot
Loading survival analyses table